ACADIA Pharmaceuticals Inc
Score: Neutral (59)
9 days at current score.
Upgraded from Negative on January 1st 2018
- This company ranked neutral compared to the Healthcare sector with only 1 positive IHS Markit Category
- ETFs holding this stock are seeing positive inflows
- Bearish sentiment is moderate and declining
Short interest | Neutral
Short interest is moderately high for ACAD with between 10 and 15% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on December 28.
ETF/Index ownership | Positive
ETF activity is positive but appears to be weakening. Over the last month, growth of ETFs holding ACAD is favorable, with net inflows of $2.82 billion. This is among the highest periods of net inflows seen over the last one-year, but the rate of additional flows appears to be decreasing.
PMI by IHS Markit | Neutral
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however.
Credit default swap
CDS data is not available for this security.
Please send all inquiries related to the report to firstname.lastname@example.org.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.